Aaron Pelta
Corporate Officer/Principal at MORPHIC HOLDING, INC.
Aaron Pelta active positions
Companies | Position | Start | End |
---|---|---|---|
MORPHIC HOLDING, INC. | Corporate Officer/Principal | 2018-12-31 | - |
Career history of Aaron Pelta
Former positions of Aaron Pelta
Companies | Position | Start | End |
---|---|---|---|
X4 Pharmaceuticals (Austria) GmbH | Corporate Officer/Principal | 2016-07-31 | 2019-02-28 |
AMAG PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2015-06-17 | 2015-10-31 |
Training of Aaron Pelta
Tuck School of Business at Dartmouth | Masters Business Admin |
Tufts University | Undergraduate Degree |
Statistics
International
United States | 5 |
Austria | 2 |
Operational
Corporate Officer/Principal | 3 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
MORPHIC HOLDING, INC. | Health Technology |
Private companies | 2 |
---|---|
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
X4 Pharmaceuticals (Austria) GmbH |
- Stock Market
- Insiders
- Aaron Pelta
- Experience